z-logo
open-access-imgOpen Access
Modulation of Free Corticotrophin-Releasing Hormone, Adrenal and Placental Steroid Hormone Levels Induced by Mifepristone during Pregnancy
Author(s) -
PierreFrançois Ceccaldi,
Julien Saada,
Mireille Nicolas,
Guillaume Ducarme,
Philippe Blot,
Jean Gadrey,
Dominique Luton
Publication year - 2012
Publication title -
fetal diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.976
H-Index - 60
eISSN - 1421-9964
pISSN - 1015-3837
DOI - 10.1159/000338927
Subject(s) - mifepristone , medicine , endocrinology , estriol , hormone , fetus , pregnancy , antiglucocorticoid , receptor , glucocorticoid receptor , biology , genetics
Mifepristone is a progesterone receptor antagonist widely used in obstetrics. The aim of the study was to focus on free corticotrophin-releasing hormone (CRH) and also describe modulation of adrenal and placental steroid hormone concentrations induced by mifepristone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom